Author:
Meyer Jonathan M.,Stahl Stephen M.
Abstract
Real-world and clinical trial data support that clozapine is the only effective antipsychotic for treatment resistant schizophrenia and other severe mental illnesses. Clozapine also reduces rates of suicidality, psychiatric hospitalization and all-cause mortality. However, clozapine is underutilized for two reasons: misunderstandings of its efficacy benefits and misapprehension of, limited knowledge or misinformation about the management of treatment related risks and adverse effects. In response to worldwide efforts to promote clozapine use, this user-friendly Handbook provides clinicians with evidence-based approaches for patient management, as well as logical approaches to the management of clinical situations and adverse effects. It outlines clearly the rationale for specific management decisions and prioritises the options based on this logic. This Handbook is designed for use by clinicians worldwide and is essential reading for all mental health care professionals.
Publisher
Cambridge University Press
Cited by
88 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Impacts of exposure to and subsequent discontinuation of clozapine on tripartite synaptic transmission;British Journal of Pharmacology;2024-08-02
2. Analysis of clinical studies on clozapine from 2012-2022;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-06-25
3. CLOZAPINE;Prescriber's Guide – Children and Adolescents;2024-05-02
4. Darth Vaper strikes again;Case Studies: Stahl's Essential Psychopharmacology;2024-04-30
5. The man whom clozapine (Clozaril) could not touch;Case Studies: Stahl's Essential Psychopharmacology;2024-04-30